Mapan-40 Pantoprazole Injection is a high-quality, sterile pharmaceutical product designed for professional medical use. Each vial contains Pantoprazole Sodium Lyophilized, equival...
Mapan-40 Pantoprazole Injection is a high-quality, sterile pharmaceutical product designed for professional medical use. Each vial contains Pantoprazole Sodium Lyophilized, equivalent to 40mg of Pantoprazole, and is supplied with 10ml of Sterile Sodium Chloride Injection IP (0.9% w/v) for easy reconstitution. This formulation ensures a rapid and effective reduction of gastric acid secretion, making it a trusted and essential tool for medical practitioners. Manufactured under rigorous quality controls, it guarantees sterility, precise potency, and patient safety. The lyophilized form enhances product stability and extends shelf life, ensuring reliable performance from storage to administration, meeting the exacting demands of modern healthcare procurement.
This injection is extensively utilized across a broad spectrum of healthcare settings. It is a standard treatment in hospitals for managing peptic ulcers, severe GERD, and other acid-related disorders. Surgical centers rely on it for perioperative acid control, while gastroenterology clinics use it for specific therapeutic protocols. Emergency medical services and critical care units employ it for urgent acid suppression and prophylaxis. Its application also extends to oncology and other specialties where patients require protective gastric management during intensive treatments. This wide-ranging utility makes it a fundamental inventory item for suppliers serving both public health systems and private medical institutions globally.
The product delivers significant value through its proven reliability and strict adherence to international pharmaceutical standards. Its consistent quality minimizes procurement risks and builds trust with end-user medical facilities. The efficacy in improving patient outcomes reinforces its reputation as a dependable therapeutic agent. Key differentiators include its sterile manufacturing process, the stability advantage of the lyophilized formulation, and a supply chain designed for bulk medical procurement. For businesses supplying the healthcare sector, it represents a low-risk, high-demand investment that aligns with the priorities of safety, clinical effectiveness, and operational efficiency in patient care.
Key Features:
- Each vial contains 40mg of Pantoprazole as a sterile lyophilized powder for injection.
- Supplied with a separate 10ml ampoule of Sterile Sodium Chloride Injection (0.9%) for reconstitution.
- Lyophilized formulation ensures enhanced stability, potency, and a longer shelf life.
- Manufactured in compliance with strict pharmaceutical standards for sterility and quality.
- Packaged to ensure integrity and safety during transport and storage.
Benefits:
- Provides fast and effective suppression of gastric acid production in clinical settings.
- Offers reliable and consistent therapeutic performance trusted by healthcare professionals.
- The sterile, ready-to-reconstitute format ensures convenience and reduces preparation errors.
- Enhanced stability allows for dependable inventory management and supply chain logistics.
- Meets the critical needs of hospitals and clinics for a proven acid-control medication.